Search
Skye Bioscience Inc
SKYEAdd to Watchlist
0.712USD
+0.000+0.03%
Market hours （ET）Quotes delayed by 15 min
25.00MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-17The current earnings forecast score of Skye Bioscience Inc is 8.00, ranking 163 out of 388 in the Biotechnology & Medical Research industry. The average price target is 10.00, with a high of 20.00 and a low of 2.00.
Analyst Rating
Based on
8
analysts
Buy
Current Rating
7.714
Target Price
+973.82%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Skye Bioscience Inc
SKYE
8
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Skye Bioscience Inc's price target?
Analysts forecast that Skye Bioscience Inc's price target is USD 10.00, with the highest forecast at USD 20.00 and the lowest forecast at USD 2.00.
How have Skye Bioscience IncSKYE's recent earnings per share performed?
The market expectation was USD -0.32, while Skye Bioscience IncSKYE's earnings per share (EPS) for the previous quarter was USD -0.36. EPS for the next quarter is expected at USD -0.25.
What is the analyst rating for Skye Bioscience Inc?
Based on the ratings of Skye Bioscience Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
